MARK SWOFFORD
Allopathic & Osteopathic Physicians|Urology GRUNDY, VA NPI 1245238484
Browse related groups: Allopathic & Osteopathic Physicians|Urology VA PROCEPT BioRobotics Corporation All categories
General Payments — all program years on this page
$3,608.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 174
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $964.36 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $964.36 | 43 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PROCEPT BioRobotics Corporation | $148.25 | 3 |
| Janssen Biotech, Inc. | $140.56 | 6 |
| EDAP TECHNOMED INC | $93.00 | 6 |
| Regeneron Healthcare Solutions, Inc. | $85.27 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $78.40 | 3 |
| Lilly USA, LLC | $67.88 | 4 |
| UROGEN PHARMA, INC. | $67.53 | 3 |
| Endo USA, Inc. | $41.72 | 2 |
| Olympus America Inc. | $40.65 | 1 |
| Merck Sharp & Dohme Corporation | $32.72 | 2 |
| PFIZER INC. | $31.79 | 2 |
| EVOKE PHARMA, INC. | $24.81 | 1 |
| Ardelyx, Inc. | $24.11 | 1 |
| Daiichi Sankyo Inc. | $21.55 | 1 |
| Acerta Pharma LLC | $18.45 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $16.63 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.54 | 1 |
| Madrigal Pharmaceuticals | $15.50 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.